FindTrial
Sign In

The role of Factor-VII activating protease in the generation of bradykinin in patients with hereditary angioedema

The role of Factor-VII activating protease in the generation of bradykinin in patients with hereditary angioedema - Factor-VII activating protease in hereditary angioedema/HAE study

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON37687
Enrollment
30
Registered
2012-07-26
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hereditary angioedema

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients suffering from hereditary angioedema Age >/ 18 yr

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
Investigate the role of factor-VII activating protease (FSAP) in the generation of bradykinin in pateints with hereditary angioedema—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)